Adherence to chronic medication in older populations: application of a common protocol among three European cohorts
暂无分享,去创建一个
Przemyslaw Kardas | Alexandra Prados-Torres | Antonio Gimeno-Miguel | Enrica Menditto | Beatriz Poblador-Plou | D. Bruzzese | P. Kardas | E. Menditto | Valentina Orlando | V. Orlando | Dario Bruzzese | Sara Malo | B. Poblador-Plou | A. Prados-Torres | Francisca González Rubio | S. Malo | E. Costa | Caitriona Cahir | Mercedes Aza-Pascual-Salcedo | Elisio Costa | A. Gimeno-Miguel | C. Cahir | F. González Rubio | M. Aza-Pascual-Salcedo | Sara Malo
[1] K. Bennett,et al. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti‐hyperglycaemic agents , 2013, Pharmacoepidemiology and drug safety.
[2] E. Menditto,et al. Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs , 2015, ClinicoEconomics and outcomes research : CEOR.
[3] E. Menditto,et al. Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications , 2017, Current medical research and opinion.
[4] V. Orlando,et al. Risk Management and Healthcare Policy Dovepress Economic Evaluation of Screening Programs for Hepatitis C Virus Infection: Evidence from Literature , 2022 .
[5] Alessandro Monaco,et al. Interventional tools to improve medication adherence: review of literature , 2015, Patient preference and adherence.
[6] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.
[7] E. Menditto,et al. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers. , 2018, Revista espanola de cardiologia.
[8] Kathleen Insel,et al. Executive function, working memory, and medication adherence among older adults. , 2006, The journals of gerontology. Series B, Psychological sciences and social sciences.
[9] A. Capaldo,et al. Osteoporosis drugs in real-world clinical practice: an analysis of persistence , 2013, Aging Clinical and Experimental Research.
[10] J. Hugtenburg,et al. Initial phase of chronic medication use; patients' reasons for discontinuation. , 2006, British journal of clinical pharmacology.
[11] M. Illario,et al. Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population , 2015, Journal of aging research.
[12] Henrik Stovring,et al. Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2 , 2009, BMC public health.
[13] A. Marengoni,et al. Toward appropriate criteria in medication adherence assessment in older persons: Position Paper , 2016, Aging Clinical and Experimental Research.
[14] T. Taylor,et al. Pharmacy Effect on Adherence to Antidiabetic Medications , 2012, Medical care.
[15] M. Illario,et al. Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy , 2016, Current diabetes reviews.
[16] J. Benner,et al. Comparing Adherence and Persistence Across 6 Chronic Medication Classes , 2009, Journal of managed care pharmacy : JMCP.
[17] E. Menditto,et al. Emerging Role of Capecitabine in Gastric Cancer , 2009, Pharmacotherapy.
[18] F. Taroni,et al. The Italian health-care system. , 2005, Health economics.
[19] K. Bennett,et al. Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data , 2017, European Journal of Clinical Pharmacology.
[20] S. De Geest,et al. Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[21] L. Manzoli,et al. Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy. , 2014, The American journal of managed care.
[22] W. Herman,et al. Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database , 2015, Diabetes Care.
[23] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[24] K. Chan,et al. Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions , 2008, Pharmacotherapy.
[25] Anuja Roy,et al. Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[26] M. Weinstein,et al. Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.
[27] F. Napolitano,et al. Medication adherence among patients with chronic conditions in Italy. , 2016, European journal of public health.
[28] G. Fico,et al. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA , 2016, The journal of nutrition, health & aging.
[29] Jerry L. Grenard,et al. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. , 2011, The American journal of geriatric pharmacotherapy.
[30] P. Kardas. Patient compliance with antibiotic treatment for respiratory tract infections. , 2002, The Journal of antimicrobial chemotherapy.
[31] F. Manguso,et al. Italian translation and cultural adaptation of the communication assessment tool in an outpatient surgical clinic , 2016, BMC Health Services Research.
[32] M. Illario,et al. Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database. , 2016, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.
[33] A. Calderón-Larrañaga,et al. Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study , 2018, International journal of epidemiology.
[34] Jeffrey K Aronson,et al. A new taxonomy for describing and defining adherence to medications. , 2012, British journal of clinical pharmacology.
[35] Kirsten Axelsen,et al. The effects of prescription drug copayments on statin adherence. , 2006, The American journal of managed care.
[36] R. Romanelli,et al. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. , 2012, Journal of the American Society of Hypertension : JASH.
[37] Przemyslaw Kardas,et al. Determinants of patient adherence: a review of systematic reviews , 2013, Front. Pharmacol..
[38] L. Pani,et al. Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification , 2016, ClinicoEconomics and outcomes research : CEOR.
[39] V. Atella,et al. The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regression , 2014, International Journal of Public Health.
[40] Steven Kahn,et al. Adherence to Preventive Medications , 2006, Diabetes Care.
[41] G. Oster,et al. Compliance with drug therapy for postmenopausal osteoporosis , 2006, Osteoporosis International.
[42] Patrik Eklund,et al. Active and Healthy Ageing and Independent Living , 2015, Journal of aging research.
[43] T. Grimes,et al. Relative accuracy and availability of an Irish National Database of dispensed medication as a source of medication history information: observational study and retrospective record analysis , 2013, Journal of clinical pharmacy and therapeutics.
[44] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[45] Patrik Eklund,et al. Active and Healthy Ageing and Independent Living 2016 , 2016, Journal of aging research.